Systems map
One model. Many interfaces.
Each pillar feeds the others. The map below shows the high-traffic relationships you'll be reasoning about clinically.
Ecological & metabolic interface
Microbiome
Signaling molecules & therapeutic messengers
Peptides
Neural regulation & neuroimmune feedback
Vagus & Autonomic
Inherited blueprint & expression layer
Genomics & Epigenomics
Feedback, safety & early-warning
Lab Testing
Filter by case
Hover a node to see its edges. Click to pin. Pick a case to dim pillars not in play.
Edges
- Genome→Peptide responseReceptor biology, drug metabolism, endocrine risk.
- Genome→MicrobiomeMucosal immunity, secretor status, barrier, bile acids, diet tolerance.
- Microbiome→EpigenomeSCFAs (HDAC), folate, B12, bile acids, indoles, inflammation.
- Vagus / autonomic tone→EpigenomeStress physiology, HPA axis, sleep, inflammation as expression modifiers.
- Labs→Genome interpretationPhenotype determines whether genomic risk is clinically active.
- Genome→Early warningFamily history, pathogenic variants, polygenic risk, pharmacogenomics.
- CRISPR / gene therapy→GenomeRegulated gene-targeted intervention for selected diseases.
- Peptides→EpigenomeInsulin, GLP-1, growth axis, sex hormones, oxytocin, inflammatory signaling.
Node lexicon
- Genome
- Epigenome
- Gene expression
- Pharmacogenomics
- Nutrigenomics
- Polygenic risk
- Monogenic risk
- Family history
- Clinically actionable variant
- Variant of uncertain significance
- DNA methylation
- Histone modification
- microRNA
- Transcriptome
- Proteome
- Metabolome
- Exposome
- CRISPR / gene editing
- RNA therapeutics
- Gene therapy
- Genetic counseling
- Cascade testing
Read the map clinically
When you click any node in your head, ask: mechanism, clinical relevance, testing options, related labs, related interventions, evidence grade, what is actionable, what is not proven, referral triggers, ethics & privacy.